Assert-IQ vs CAC Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Abbott Medical
VS
by Imbio

AI Verdict

Assert-IQ focuses on long-term, continuous monitoring of cardiac electrical activity to detect and manage heart rhythm disorders. In contrast, Imbio's CAC Software analyzes non-contrast chest CT scans to quantify coronary artery calcification for cardiovascular disease risk assessment. While both are AI-powered tools in cardiology, they address distinct clinical problems and utilize different data inputs.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous monitoring for patients with suspected or intermittent heart rhythm disorders that may not be captured by shorter-term methods. This tool is ideal for comprehensive arrhythmia detection and remote management over several years, providing proactive alerts and patient-logged symptoms to aid in diagnosis and treatment decisions.

View Assert-IQ →

Choose CAC Software if…

Choose CAC Software if you need to quickly and accurately assess a patient's risk for coronary artery disease using existing non-contrast chest CT scans. This solution is best suited for quantifying coronary artery calcification, generating key scores like the Agatston score, and providing visual insights to support cardiovascular risk stratification in a non-invasive manner.

View CAC Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Assert-IQ CAC Software
Pricing Enterprise Contact for pricing
Deployment Hybrid Cloud, On-premise, Partner platforms
FDA Status Cleared AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Imbio CAC Software wins for its fully automated processing and seamless integration into existing DICOM viewing workflows, requiring no new user interfaces or manual intervention for clinicians. This approach minimizes workflow disruption and learning curves, making it highly usable within a radiology department.

Clinical Value

Assert-IQ

Assert-IQ provides superior long-term, continuous cardiac monitoring for up to six years, coupled with advanced AI algorithms that significantly reduce false positives in arrhythmia detection. This comprehensive and accurate data is crucial for diagnosing intermittent cardiac conditions and guiding critical treatment decisions, such as anticoagulation for AF patients.

Pricing & Value

Tie

Both tools utilize an enterprise pricing model that requires direct contact for details and neither offers a free trial [cite: JSON]. Without specific pricing information or detailed cost-benefit analyses, it is not possible to determine which tool offers better overall value.

Enterprise Readiness

CAC Software

Imbio CAC Software demonstrates stronger enterprise readiness through its flexible deployment options (cloud, on-premise, and multiple partner platforms) and its fully automated integration into existing DICOM viewing workflows. This broad compatibility and seamless integration reduce implementation barriers for large health systems.

Innovation

CAC Software

Imbio CAC Software is more innovative by leveraging deep-learning based analysis to fully automate and comprehensively quantify coronary artery calcification from various existing CT scan types, including low-dose and ungated scans. This allows for opportunistic screening and provides richer risk assessment metrics beyond traditional scores, extracting new value from routine imaging data.

Support & Docs

Tie

Both Abbott (Tool A) and Imbio (Tool B) provide extensive support resources, including detailed user manuals for clinicians and patients, and accessible contact channels for technical and clinical assistance. The available information suggests comparable levels of commitment to user support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Assert-IQ CAC Software
Name Assert-IQ CAC Software
Company Abbott Medical Imbio
Description The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. Imbio's Coronary Artery Calcification (CAC) software is a set of automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT).
Key Features Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion Automated image post-processing for coronary artery calcification, Quantification of calcification within coronary arteries, Outputs Agatston score, arterial age, calcified lesion mass and volume, Provides 3D visualizations and annotated images, Non-invasive analysis from non-contrast chest CT scans, Integrates into existing DICOM viewing workflow, Supports risk assessment for coronary artery disease, Deep-learning based analysis
Specialties Cardiology, Internal Medicine Cardiology, Radiology
Target Size Large health systems, hospitals, cardiology clinics Not specified

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and CAC Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Assert-IQ is designed for long-term, continuous monitoring and advanced arrhythmia detection to diagnose and manage patients with suspected heart rhythm disorders. In contrast, Imbio's CAC Software helps determine the location and quantify coronary artery calcification from non-contrast chest CT scans to support risk assessment for coronary artery disease.
Assert-IQ requires the minimally invasive insertion of an Insertable Cardiac Monitor (ICM) to provide continuous cardiac monitoring for up to six years. Imbio's CAC Software, however, performs non-invasive analysis by post-processing existing non-contrast chest computed tomography (CT) scans.
Assert-IQ provides advanced arrhythmia detection algorithms, proactive clinician alerts, and allows for patient symptom logging. Imbio's CAC Software outputs the Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images.
Assert-IQ is best suited for patients with suspected heart rhythm disorders requiring long-term, continuous cardiac monitoring. Imbio's CAC Software is designed for patients who have undergone a non-contrast chest CT, assisting radiologists and cardiologists in assessing coronary artery disease risk.
Assert-IQ utilizes a secure cloud-based data platform with remote monitoring capabilities and Bluetooth Low Energy data transmission. Imbio's CAC Software integrates directly into existing DICOM viewing workflows, providing automated image post-processing.
Assert-IQ offers long-term continuous cardiac monitoring for up to 6 years, providing ongoing data. Imbio's CAC Software provides a snapshot analysis of coronary artery calcification from a single non-contrast chest CT scan.
AI Tool Finder
AI-powered search. Results may not be comprehensive.